Relapsed or Refractory Follicular Lymphoma
Also known as: Relapsed and Refractory Follicular Lymphoma / Relapsed/Refractory Follicular Lymphoma / Relapsed / Refractory Follicular Lymphoma
Drug | Drug Name | Drug Description |
---|---|---|
DB15434 | Mosunetuzumab | A humanized anti-CD20/CD3 bispecific antibody used to treat relapsed or refractory follicular lymphoma. |
Drug | Drug Name | Target | Type |
---|---|---|---|
DB15434 | Mosunetuzumab | B-lymphocyte antigen CD20 | target |
DB15434 | Mosunetuzumab | T-cell surface glycoprotein CD3 epsilon chain | target |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB00531 | Cyclophosphamide | 1 | Active Not Recruiting | 1 |
DB01073 | Fludarabine | 1 | Active Not Recruiting | 1 |
DB16272 | Orelabrutinib | 2 | Recruiting | 1 |
DB00073 | Rituximab | 2 | Recruiting | 1 |
DB13915 | Axicabtagene ciloleucel | 3 | Recruiting | 1 |
DB06769 | Bendamustine | 3 | Not Yet Recruiting | 1 |
DB06769 | Bendamustine | 3 | Recruiting | 1 |
DB00531 | Cyclophosphamide | 3 | Not Yet Recruiting | 1 |
DB00531 | Cyclophosphamide | 3 | Recruiting | 1 |
DB00997 | Doxorubicin | 3 | Not Yet Recruiting | 1 |
DB00997 | Doxorubicin | 3 | Recruiting | 1 |
DB01073 | Fludarabine | 3 | Not Yet Recruiting | 1 |
DB01073 | Fludarabine | 3 | Recruiting | 1 |
DB00480 | Lenalidomide | 3 | Not Yet Recruiting | 1 |
DB00480 | Lenalidomide | 3 | Recruiting | 5 |
DB16582 | Lisocabtagene maraleucel | 3 | Not Yet Recruiting | 1 |
DB15434 | Mosunetuzumab | 3 | Recruiting | 1 |
DB08935 | Obinutuzumab | 3 | Recruiting | 1 |
DB16684 | Odronextamab | 3 | Recruiting | 1 |
DB00635 | Prednisone | 3 | Not Yet Recruiting | 1 |
DB00635 | Prednisone | 3 | Recruiting | 1 |
DB00073 | Rituximab | 3 | Not Yet Recruiting | 1 |
DB00073 | Rituximab | 3 | Recruiting | 5 |
DB12887 | Tazemetostat | 3 | Recruiting | 1 |
DB00541 | Vincristine | 3 | Not Yet Recruiting | 1 |
DB00541 | Vincristine | 3 | Recruiting | 1 |
DB15035 | Zanubrutinib | 3 | Recruiting | 1 |